Provides standards for correctional facilities in relation to medication assisted treatment for opioid use disorders and the testing for opioid use when an individual is first incarcerated.
Summary
Bill A04062 aims to amend the correction law and the mental hygiene law to establish standards for providing medication-assisted treatment (MAT) for opioid use disorders to individuals incarcerated in county correctional facilities. It mandates medical testing for opioid use upon incarceration and ensures that those who test positive are informed of their eligibility for MAT. The bill outlines the responsibilities of local correctional facilities in implementing substance use disorder treatment and transition services, requiring collaboration with various stakeholders to create effective treatment plans tailored to individual needs.
Impact
If enacted, this bill would significantly alter the approach to opioid addiction treatment within county jails in New York. It would require jails to implement structured MAT programs and ensure that individuals with opioid use disorders receive appropriate medical care while incarcerated. This could lead to improved health outcomes for incarcerated individuals and potentially reduce recidivism rates associated with substance use disorders, as it emphasizes continuity of care and individualized treatment plans.
Sentiment
The general sentiment surrounding Bill A04062 appears to be supportive, with discussions emphasizing the importance of addressing opioid addiction in correctional settings. Stakeholders recognize the need for effective treatment options to improve the health of incarcerated individuals and reduce the stigma associated with substance use disorders. However, there may be concerns regarding the implementation logistics and resource allocation for these programs.
Contention
Notable points of contention may arise regarding the adequacy of resources available to local correctional facilities to implement the required MAT programs effectively. Some stakeholders may question whether the facilities can meet the standards set forth in the bill, particularly in areas with limited access to medical professionals or treatment resources. Additionally, there may be differing opinions on the balance between treatment and security concerns within correctional environments.
Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)